
Medpace Holdings MEDP
Quartalsbericht 2026-Q1
hinzugefügt 23.04.2026
Medpace Holdings DSO 2011-2026 | MEDP
DSO Jährlich Medpace Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.4 | 51.5 | 53.4 | 55 | 55.5 | 62.4 | 66 | 69.1 | 69.5 | 69.1 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 69.5 | 50.4 | 60.2 |
DSO Vierteljährlich Medpace Holdings
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.4 | - | 51.9 | 51.1 | 48.6 | - | 52.4 | 50.1 | 51.6 | - | 52.6 | 52.8 | 53.7 | - | 29.6 | 29.2 | 56.7 | - | 53.7 | 52.7 | 56.3 | - | 63.8 | 71.7 | 62.6 | 61.8 | 65.7 | 66.3 | 65.7 | 63.4 | 67.9 | 71.6 | 60.6 | 67.3 | 68.5 | 71.4 | 69.7 | - | 67.5 | 68.7 | 66.4 | - | 32.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 71.7 | 29.2 | 57.9 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Myriad Genetics
MYGN
|
52.3 | $ 4.11 | -18.29 % | $ 381 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.86 | -4.7 % | $ 400 M | ||
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
31.7 | $ 17.01 | -0.09 % | $ 179 M | ||
|
Agilent Technologies
A
|
63.8 | $ 117.69 | 0.14 % | $ 35.8 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 20.94 | 1.16 % | $ 1.12 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 1.64 | 3.14 % | $ 2.18 M | ||
|
Castle Biosciences
CSTL
|
50.2 | $ 24.75 | 0.61 % | $ 687 M | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 181.73 | -1.97 % | $ 9.01 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
77.7 | $ 8.89 | 0.34 % | $ 1.14 B | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
Natera
NTRA
|
81.5 | $ 215.09 | 4.02 % | $ 21.2 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 14.92 | 0.13 % | $ 451 M | ||
|
Personalis
PSNL
|
55.8 | $ 6.07 | 9.17 % | $ 360 M | ||
|
Guardant Health
GH
|
46.1 | $ 92.25 | 3.05 % | $ 11.6 B | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
Soleno Therapeutics
SLNO
|
27 | $ 52.94 | 0.04 % | $ 2.69 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 124.13 | 2.32 % | $ 10.2 B | ||
|
Illumina
ILMN
|
61.3 | $ 142.58 | 2.52 % | $ 22.7 B | ||
|
Senseonics Holdings
SENS
|
10.3 | $ 5.36 | 7.2 % | $ 224 M | ||
|
Interpace Biosciences
IDXG
|
66.9 | - | - | $ 9.33 M | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 472.95 | 1.33 % | $ 178 B | ||
|
Biomerica
BMRA
|
57.7 | $ 2.21 | 1.14 % | $ 5.08 M | ||
|
Trinity Biotech plc
TRIB
|
87.2 | $ 0.6 | 0.42 % | $ 61.9 M | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 86.15 | 0.38 % | $ 5.81 B | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 256.94 | -0.08 % | $ 21.4 B | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 59.53 | 4.99 % | $ 3.56 B | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 9.18 | -0.97 % | $ 1.99 B | ||
|
Waters Corporation
WAT
|
306 | $ 349.53 | 1.98 % | $ 20.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 189.13 | -0.9 % | $ 21 B |